The NovaLisa Chagas IgG Test is a reliable and highly specific ELISA assay for the qualitative detection of IgG antibodies against Trypanosoma cruzi, the causative agent of Chagas disease. This test is optimized for the diagnosis of chronic Chagas infections in human serum or plasma samples. Incorporating recombinant antigens for enhanced specificity, the assay includes pre-coated microplates, ready-to-use reagents, and is compatible with fully automated ELISA systems. Its robust performance, high throughput capacity, and CE-IVD compliance make it a trusted choice for diagnostic laboratories, epidemiological studies, and routine serological testing.